Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: KHK2375|DRUG: Exemestane
Sponsor: Kyowa Kirin Co., Ltd.